Health
Spark Therapeutics launches gene therapy clinical trial for late-onset Pompe disease – News-Medical.Net
Pompe disease is a hereditary genetic disorder caused by a deficiency of acid alpha-glucosidase leading to build-up of glycogen in the lyosomes, which then causes…
Pompe disease is a hereditary genetic disorder caused by a deficiency of acid alpha-glucosidase leading to build-up of glycogen in the lyosomes, which then causes cell damage in various tissues, in particular the heart, the muscles, the liver and the nervous system.
In patients living with late-onset Pompe disease the respiratory system and mobility are most frequently the most affected by the disease, often requiring the use of a wheelchair and respiratory assistance, and life expectancy can be…
-
Noosa News23 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News23 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General9 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council
-
General24 hours agoLabor to squeeze public service, sparking warnings of job losses